Description and Brand Names
Drug information provided by: IBM Micromedex
US Brand Name
Meningococcal polysaccharide vaccine and Haemophilus B conjugate vaccine is an active immunizing combination agent that is used to prevent infection caused by certain groups of meningococcal bacteria and Haemophilus influenza type b (Hib) bacteria. The vaccine works by causing your body to produce its own protection (antibodies) against the disease.
The following information applies only to the meningococcal vaccine used for meningococcal bacteria Groups C and Y
Menhibrix® vaccine is recommended for use in children 6 weeks to 18 months of age.
This vaccine is to be administered only by or under the direct supervision of your doctor.